The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review

To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors. A systematic literature search to identify randomized trials comparing chemotherapy with and without Bevacizumab in metastatic cancer. The primary end point was overal...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2013-01, Vol.8 (1), p.e51780
Hauptverfasser:	Amit, Limor, Ben-Aharon, Irit, Vidal, Liat, Leibovici, Leonard, Stemmer, Salomon
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Angiogenesis inhibitors Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - pharmacology Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Breast cancer Cancer Cancer metastasis Care and treatment Chemotherapy Clinical trials Colorectal cancer Health risks Hemorrhage Humans Immunotherapy Lung cancer Lung diseases Medicine Meta-analysis Metastases Monoclonal antibodies Neoplasm Metastasis Neoplasms - drug therapy Neoplasms - pathology Patients Randomization Risk Solid tumors Statistical analysis Studies Survival Survival Analysis Systematic review Targeted cancer therapy Toxicity Tumors Vascular endothelial growth factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!